Xoft

Radiation Therapy Equipmentxoftinc.com

Company typePrivate
Founded1998
HeadquartersSan Jose, United States
Headcount51–100
GTM typeB2B
OfferingHardware or Manufacturing

Xoft firmographics

Firmographics

Name: Xoft
Legal name: Elekta
Website: https://xoftinc.com
Company type: Private
Founded year: 1998
Operating status: Operating
Headcount range: 51–100 employees
Ownership category
akta.pro rank

Xoft industry classification

Industry

Product category: Radiation Therapy Equipment
NAICS: Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC: X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry: Radiation Oncology (HLAKAFAC)
akta.pro secondary industries: Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC), Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine) (HLAIAGAJ)

Keywords

Electronic brachytherapy systems
Radiation oncology devices
Intraoperative radiation therapy
Cancer treatment equipment
Brachytherapy applicators

Where Xoft is headquartered

Location

Headquarters

HQ city: San Jose
HQ country: United States
HQ region: North America

Markets served

Xoft business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

Medical Device Hardware Sales: Sale of Elekta Xoft Axxent Electronic Brachytherapy System and associated applicators including balloon, surface, vaginal, and cervical applicators. One-time capital equipment sale with accompanying consumables and accessories.
Service and Support Contracts: Ongoing maintenance, support, and service contracts through Elekta Care platform for installed base of Xoft systems.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Xoft product offering

Product offering

Core offering

Xoft designs and manufactures the Elekta Xoft Axxent Electronic Brachytherapy (eBx) System, a portable radiation therapy device that uses a 50 kV miniaturized X-ray source to deliver low-energy, high-dose-rate localized radiation for breast, skin, and gynecological cancers. The system is supported by a family of applicators (balloon, surface, vaginal, cervical) and shielding accessories that allow treatment in standard outpatient rooms and operating theaters without dedicated bunker infrastructure.

Product overview

Elekta Xoft is an electronic brachytherapy (eBx) platform consisting of the Axxent Electronic Brachytherapy System as the core product, complemented by a range of applicators (Balloon, Surface, Vaginal, and Cervical), shielding accessories (FlexiShield and Rigid Shield), and supporting components (Controller, Physics Accessories Kit, and Hub). The system delivers low-energy (50 kV) high dose rate radiation therapy using a miniaturized X-ray source for multiple clinical indications including early-stage breast cancer, non-melanoma skin cancer (NMSC), and gynecological cancers, as well as intraoperative radiation therapy (IORT) applications. The platform is designed for portability and accessibility, requiring no bunker or dedicated shielding, allowing treatment in various clinical settings from standard outpatient rooms to operating theaters.

Differentiator

Problem solved

Functional benefit

Brands

Xoft Axxent Electronic Brachytherapy (eBx) System: Portable electronic brachytherapy system for cancer treatment requiring no bunker or dedicated shielding, using a 50 kV miniaturized X-ray source for low energy, high dose rate localized radiation therapy.

Products and services

Elekta Xoft Axxent Electronic Brachytherapy (eBx) System
Xoft Controller
Xoft Balloon Applicator
Xoft Surface Applicator
Xoft Vaginal Applicator
Xoft Cervical Applicator
FlexiShield
Rigid Shield
Physics Accessories Kit
Xoft Hub
Breast eBx
Skin eBx
GYN eBx

Quantifiable outcome

Market projected to double from USD 60 million to USD 120 million by 2030

Companies that use Xoft

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles1 record

Xoft technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Xoft partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor.

Martin Health SystemminorOthersCase study customer using Elekta Xoft for electronic brachytherapy treatment at Stuart, FL location. Demonstrates real-world implementation and clinical outcomes.
Monash Cancer CentreminorOthersCase study customer in Victoria, Australia using Elekta Xoft for cancer treatment. Demonstrates international adoption of the technology.
Lutheran HospitalminorOthersCase study customer at Fort Wayne, IN using Elekta Xoft for electronic brachytherapy treatments.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Xoft competitors and assessment

Company assessment

Direct peers

Varian Medical Systems (Siemens Healthineers): Varian is the largest global competitor in radiation oncology and brachytherapy, offering HDR afterloaders (e.g., Bravos/Gammamed), applicators, and treatment planning software that compete head-to-head with Xoft's eBx system across breast, skin, and GYN indications.
Elekta Flexitron / Venezia / Geneva (brachytherapy line): Within the same parent company, Elekta's Flexitron HDR afterloader and Venezia/Geneva GYN applicators are the primary competing brachytherapy modalities for the same clinical indications Xoft targets, and compete for internal R&D and commercial attention.
IntraOp Medical: IntraOp manufactures the Mobetron intraoperative electron-beam radiation therapy (IOERT) system used in IORT workflows that directly overlap with Xoft's breast IORT use case at cancer surgery centers.
Sensus Healthcare: Sensus Healthcare sells the SRT-100 superficial radiation therapy system for non-melanoma skin cancer, directly competing with Xoft's Skin eBx indication and targeting the same dermatology and oncology office-based setting.
iCAD (Xoft skin brachytherapy): iCAD previously owned and commercialized the original Xoft Axxent electronic brachytherapy system before the Elekta acquisition and remains active in X-ray-based brachytherapy, making it a direct eBx peer.

Broad incumbents

Carl Zeiss Meditec: ZEISS offers the INTRABEAM single-channel intraoperative radiotherapy system for IORT, which is the closest direct technical comparator to Xoft's eBx in breast and other surgical oncology workflows.
Accuray: Accuray sells CyberKnife and TomoTherapy radiation therapy systems that compete for cancer-center capex and patient share against Xoft's brachytherapy solutions in adjacent oncology indications.

Emerging players

RefleXion Medical: RefleXion develops biology-guided radiotherapy (BgRT) and PET-guided treatment systems that represent an emerging external-beam alternative for cancer indications currently addressed by Xoft's brachytherapy products.
ViewRay: ViewRay's MRIdian MR-guided radiation therapy system competes for the same hospital capital equipment budgets and oncology patient referrals targeted by Xoft's eBx platform.

Others

Elekta Kaiku Health (life sciences): Elekta's life sciences digital health portfolio sits within the same parent company and represents an enabling software/patient engagement layer that could integrate with Xoft eBx workflows to enhance outcomes tracking and value-based reimbursement positioning.

Market position

Strengths2 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Xoft financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Xoft leadership team

Management profile

Number of profiles

Profiles1 record

Xoft funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Xoft M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xoft

What does Xoft do?

Is Xoft a public or private company?

Xoft is a private company. It is classified as corporate owned and is currently operating.

When was Xoft founded?

Xoft was founded in 1998. It employs 51 to 100 people.

Where is Xoft based?

Xoft is headquartered in San Jose, United States, in the North America region.

How does Xoft make money?

Two revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are service and Support Contracts.

Who are Xoft's main competitors?

Direct peers on record are Varian Medical Systems (Siemens Healthineers), Elekta Flexitron / Venezia / Geneva (brachytherapy line), IntraOp Medical, Sensus Healthcare and iCAD (Xoft skin brachytherapy). Broad incumbents are Carl Zeiss Meditec and Accuray. Emerging players are RefleXion Medical and ViewRay. Elekta Kaiku Health (life sciences) is listed as an others.

Does Xoft have an API?

No public API is recorded for Xoft.

What industry is Xoft in?

Xoft's product category is Radiation Therapy Equipment. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser). Its NAICS code is 334517 and its SIC code is 3844.